Skip to main content
Fig. 7 | BMC Rheumatology

Fig. 7

From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

Fig. 7

Anti-Spike IgG levels according to different drug use in patients on IS medications by different vaccine groups (* median anti-Spike IgG levels were shown) (MTX: Methotrexate, CS: Corticosteroid, HCQ: Hydroxychloroquine, LEF: Leflunomide, TNFi: Tumor Necrosis Factor inhibitors, SSZ: Sulfasalazine)

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us